GADGVGKSA
GADGVGKSA is a mutant KRAS G12D 9mer peptide. GADGVGKSA can be used as an immunogenic neoantigen for cancer immunotherapy research[1].
Product Specifications
CAS Number
[2032119-68-7]
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gadgvgksa.html
Purity
99.31
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC([C@H](C)NC([C@H](CO)NC([C@H](CCCCN)NC(CNC([C@H](C(C)C)NC(CNC([C@H](CC(O)=O)NC([C@H](C)NC(CN)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C30H52N10O13
Molecular Weight
760.79
References & Citations
[1]Bai P, et al. Characters of neoantigens in cancer immunotherapy. bioRxiv, 2019: 700732.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
